Global HER-2 Negative Breast Cancer Market Share

Statistics for the 2023 & 2024 Global HER-2 Negative Breast Cancer market share, created by Mordor Intelligence™ Industry Reports. Global HER-2 Negative Breast Cancer share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Pharmaceuticals Research Disease Specific Drugs Research Chronic Disorder Drugs Research Oncology Drugs Research Triple-negative Breast Cancer Industry Market Share

Market Share of Global HER-2 Negative Breast Cancer Industry

The primary focus among the companies is to develop combination therapies that shall overcome the resistance of existing drug therapies in the market thus boosting the targeted disease treatment. This is done via collaboration and partnerships among the market players. Some major companies in this segment include AstraZeneca, Bristol-Myers Squibb Company (Celgene Corporation), Eli Lilly and Company, GSK plc., Merck & Co., Inc., Novartis AG, and Pfizer Inc.

HER-2 Negative Breast Cancer Market Leaders

  1. Eli Lilly and Company

  2. AstraZeneca

  3. GSK

  4. Novartis AG

  5. Pfizer

*Disclaimer: Major Players sorted in no particular order

Picture1.png

Breast Cancer Market Report Snapshots

HER-2 Negative Breast Cancer Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)